Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer.
Warren JD, Xiong W, Bunker AM, Vaughn CP, Furtado LV, Roberts WL, Fang JC, Samowitz WS, Heichman KA. · 2011
Read Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer. by Warren JD, Xiong W, Bunker AM, Vaughn CP, Furtado LV, Roberts WL, Fang JC, Samowitz WS, Heichman KA. (2011) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc3271041.txt.
Description
Jorja Warren and colleagues validated a blood test for colorectal cancer based on a methylated DNA marker, in this 2011 paper in BMC Medicine. About half of Americans in the screening age range skip recommended screening, leaving tens of millions untested. A simple blood draw could bring many of them in, catching cancers earlier.
The test looks for methylated Septin 9 DNA in plasma. In samples from cancer patients, healthy controls, and colonoscopy patients, the improved assay caught ninety percent of colorectal cancers while correctly clearing eighty-eight percent of people without the disease. It worked for early-stage cancers and for tumors anywhere in the colon, including hard-to-reach regions. False positives ran at about twelve percent. It also detected a small share of precancerous adenomas. The authors propose offering it to average-risk adults unwilling or unable to have a colonoscopy.
Catalog record
| CREATOR | Warren JD, Xiong W, Bunker AM, Vaughn CP, Furtado LV, Roberts WL, Fang JC, Samowitz WS, Heichman KA. |
|---|---|
| YEAR | 2011 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 35 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |